Research And Development Tenders

Refurbishment of Apartments

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Infliximab (Atc Code: L04ab02).

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Rituximab (Atc Code: L01fa01).

Open Framework Agreement on Discounts in Accordance with § 130A Paragraph 8 Sgb V with the Option of Joining at any Time, So-Called Approval Model for Blood Sugar Test Strips for the State of North Rhine-Westphalia

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Conclusion of Non-Exclusive Discount Agreements in Accordance with § 130A Paragraph 8 Sgb V for Pharmaceuticals (Open House Procedure)

Open Framework Agreement on Drug Discounts in Accordance with § 130A Paragraph 8 Sgb V with the Option to Join at any Time, So-Called Approval Model 2023-06

Conclusion of Non-Exclusive Discount Agreements According to §130A Para.8 Sgb V for Various Active Ingredient(S)/Combinations with the Possibility of Conclusion at any Time as Part of the So-Called Open House Procedure

Open House Original Discount Contracts 2023-19 - Glycopyrronium Bromide/Formoterol (Combination of Active Ingredients)